Lung cancer screening update

Journal of Thoracic Imaging

Volumn 31, Issue 4, 2016, Pages 190-200

  Ruchalski, Kathleen L ^a   Brown, Kathleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Computed tomography; Lowdose computed tomography; Lung cancer screening; Lung RADS; Nodule management

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; HEALTH CARE DISPARITY; HEALTH CARE PLANNING; HUMAN; INFORMATION PROCESSING; LUNG CANCER; MULTICENTER STUDY (TOPIC); PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; RISK ASSESSMENT; SHARED DECISION MAKING; SMOKING CESSATION; SOCIOECONOMICS; SYSTEMATIC REVIEW (TOPIC); THORAX RADIOGRAPHY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG; LUNG TUMOR; MASS SCREENING; PROCEDURES; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG; LUNG NEOPLASMS; MASS SCREENING; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84975887008     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0000000000000221     Document Type: Article

References (70)

1. American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.
2. National Lung Screening Trial Research Team. The National Lung Screening Trial: Overview and study design. Radiology. 2011;258:243-253.
3. National Lung Screening Trial Research Team. Reduced lungcancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
4. Gutierrez A, Suh R, Abtin F, et al. Lung cancer screening. Semin Interv Radiol. 2013;30:114-120.
5. Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369:920-931.
6. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307:2418-2429.
7. Goulart BHL, Ramsey SD. Moving beyond the National Lung Screening Trial: discussing strategies for implementation of lung cancer screening programs. Oncologist. 2013;18:941-946.
8. Field JK, Van Klaveren R, Pedersen JH, et al. European randomized lung cancer screening trials: Post NLST. J Surg Oncol. 2013;108:280-286.
9. Heuvelmans MA, Vliegenthart R, Oudkerk M. Contribution of the European Trials (European Randomized Screening Group) in computed tomography lung cancer screening. J Thorac Imaging. 2015;30:101-10710.
10. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67:296-301.
11. Agency for Healthcare Research and Quality. Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High Risk Populations. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
12. Moyer VA. Screening for lung cancer: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. 2014; 160:I-40.
13. Jensen TS, Chin J, Ashby L, et al. Decision memo for screening for lung cancer with low dose computed tomography (LDCT). Centers for Medicare and Medicaid Services. 2015.
14. Eberth JM, Sercy E. Implementation of lung cancer screening in the United States: changing trends based on a survey of Society of Thoracic Radiology members. J Thorac Imaging. 2015;30:W60-W62.
15. McKee BJ, McKee AB, Kitts AB, et al. Low-dose Computed tomography screening for lung cancer in a clinical setting: Essential elements of a screening program. J Thorac Imaging. 2015;30:115-129.
16. Iaccarino JM, Clark J, Bolton R, et al. A national survey of pulmonologists' views on low-dose computed tomography screening for lung cancer. Ann Am Thorac Soc. 2015;12: 1667-1675.
17. Kazerooni EA, Austin JHM, Black WC, et al. ACR-STR practice parameters for the performance and reporting of lung cancer screening thoracic computed tomography (CT). J Thorac Imaging. 2014;29:310-316.
18. Fintelmann FJ, Berheim A, Digumarthy SR, et al. The 10 pillars of lung cancer screening: rationale and logistics of a lung cancer screening program. RadioGraphics. 2015;35: 1893-1908.
19. Wiener RS, Gould MK, Arenberg DA, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: Implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015;192:881-891.
20. Informed Medical Decisions Foundation. What is shared decision making? Available at: http://www.informedmedicaldecisions.org/what-is-shared-decision-making. Accessed January 25, 2016.
21. Caverly T. Selecting the best candidates for lung cancer screening. JAMA Intern Med. 2015;175:898-900.
22. Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One. 2009;4:e4705.
23. Volk RJ, Linder SK, Leal VB, et al. Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prevent Med. 2014;62:60-63.
24. Stacey D, Bennett C, Barry M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014:1-332.
25. Lau YK, Caverly TJ, Cao P, et al. Evaluation of a personalized, web-based decision aid for lung cancer screening. Am J Prevent Med. 2015;49:e125-e129.
26. Van der Aalst CM, Van den Bergh KAM, Willemsen MC, et al. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax. 2010;65:600-605.
27. Tammemägi MC, Berg CD, Riley TL, et al. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014;106:dju084.
28. Barry SA, Tammemägi MC, Penek S, et al. Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst. 2012; 104:1647-1659.
29. Pua BB, Dou E, O'Connor K, et al. Integrating smoking cessation into lung cancer screening programs. Clin Imaging. 2016;40:302-306.
30. Ostroff JS, Copeland A, Borderud SP, et al. Readiness of lung cancer screening sites to deliver smoking cessation treatment: Current practices, organizational priority, and perceived barriers. Nicotine Tob Res. 2015;18:1067-1075.
31. Taylor KL, Cox LS, Zincke N, et al. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007; 56:125-134.
32. Zeliadt SB, Heffner JL, Sayre G, et al. Attitudes and perceptions about smoking cessation in the context of lung cancer screening. JAMA Intern Med. 2015;175:1530-1537.
33. Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services; 2008.
34. Alberg AJ, Brock MV, Ford JG, et al. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e1S-e29S.
35. Centers for Disease Control Prevention. Morbidity and mortality week report. Cigarette Smoking Among Adults-United States 2006. 2007;56:1157-1161.
36. Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen. 2012;19:154-156.
37. Wood DE. National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening. Thorac Surg Clin. 2015;25:185-197.
38. Jacobson FL, Austin JHM, Field JK, et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for lung cancer screening and surveillance. J Thorac Cardiovasc Surg. 2012; 144:25-32.
39. McKee BJ, Hashim JA, French RJ, et al. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol. 2015;12:192-197.
40. Pinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20-29 pack-year smokers: Implications for screening. J Natl Cancer Inst. 2015;107:djv226.
41. Wang Y, Midthun DE, Wampfler JA, et al. Trends in the proportion of patients with lung cancer meeting screening criteria. JAMA. 2015;313:853-855.
42. Tammemägi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011;103:1058-1068.
43. Tammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever-and neversmokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014;11:e1001764.
44. Kovalchik SA, Tammemägi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369:245-254.
45. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2012/, based on November 2014 SEER data submission, posted to the SEER web site. Accessed April 2015.
46. Stellman SD, Chen Y, Muscat JE, et al. Lung cancer risk in white and black Americans. Ann Epidemiol. 2003;13:294-302.
47. Pinsky P. Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States). Cancer Causes Control. 2006;17: 1017-1024.
48. Fiscella K, Winters P, Farah S, et al. Do lung cancer eligibility criteria align with risk among blacks and Hispanics? PLoS One. 2015;10:e0143789.
49. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults. National health interview survey, 2005. National Center for Health Statistics. Vital Health Stat. 2006;10:232.
50. Sonnenfeld N, Schappert SM, Lin SX. Racial and ethnic differences in delivery of tobacco-cessation services. Am J Prev Med. 2009;36:21-28.
51. Li F, Sone S, Abe H, et al. Lung cancers missed at low-dose helical CT screening in a general population: Comparison of clinical, histopathologic, and imaging findings. Radiology. 2002;225:673-683.
52. Armato SG, Li F, Giger ML, et al. Lung cancer: Performance of automated lung nodule detection applied to cancers missed in a CT screening program. Radiology. 2002;225:685-692.
53. Amir GJ, Lehmann HP. After detection: The improved accuracy of lung cancer assessment using radiologic computer-aided diagnosis. Acad Radiol. 2016;23:186-191.
54. ECRI Institute. Computed Tomography with Computer-aided Detection for Lung Cancer Screening. Plymouth Meeting, PA: ECRI Institute; 2015.
55. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Cancer Netw. 2012;10:240-265.
56. American College of Radiology. Lung CT screening reporting and data system (Lung-RADS). Available at: http://www.acr. org/Quality-Safety/Resources/LungRADS. Accessed December 9, 2015.
57. McKee BJ, Regis SM, McKee AB, et al. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015;12:273-276.
58. Pinsky PF, Gierada DS, Black W, et al. Performance of LungRADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med. 2015;162:485-491.
59. McWilliams A, Tammemägi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369:910-919.
60. Gatenby RA, Grove O, Gillies RJ. Quantitative imaging in cancer evolution and ecology. Radiology. 2013;269:8-14.
61. Maldonado F, Boland J, Raghunath S, et al. Non-invasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using Computer Aided Nodule Assessment and Risk Yield (CANARY)-a Pilot Study. J Thorac Oncol. 2013;8:452-460.
62. Gierada DS, Pilgram TK, Ford M, et al. Lung cancer: Interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology. 2008;246: 265-272.
63. Singh S, Pinsky P, Fineberg NS, et al. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology. 2011;259:263-270.
64. Schwartz LH, Panicek DM, Berk AR, et al. Improving communication of diagnostic radiology findings through structured reporting. Radiology. 2011;260:174-181.
65. Larson DB, Towbin AJ, Pryor RM, et al. Improving consistency in radiology reporting through the use of department-wide standardized structured reporting. Radiology. 2013; 267:240-250.
66. Mazzone P, Powell CA, Arenberg D, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society policy statement. Chest. 2015;147:295-303.
67. Woloshin S, Schwartz LM, Dann E, et al. Using radiology reports to encourage evidence-based practice in the evaluation of small, incidentally detected pulmonary nodules. A preliminary study. Ann Am Thorac Soc. 2013;11:211-214.
68. Slatore CG, Horeweg N, Jett JR, et al. An official American Thoracic Society research statement: a research framework for pulmonary nodule evaluation and management. Am J Respir Crit Care Med. 2015;192:500-514.
69. Reid AE, Tanoue L, Detterbeck F, et al. The role of the advanced practitioner in a comprehensive lung cancer screening and pulmonary nodule program. J Adv Pract Oncol. 2014; 5:440-446.
70. Boiselle PM, Chiles C, Ravenel JG, et al. Computed tomographic screening for lung cancer trends at leading academic medical centers from 2013 to 2015. JAMA Oncol. 2016. [Epub ahead of print].